{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:48:16Z","timestamp":1784141296789,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,27]],"date-time":"2018-01-27T00:00:00Z","timestamp":1517011200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s12020-018-1523-6","type":"journal-article","created":{"date-parts":[[2018,1,27]],"date-time":"2018-01-27T02:34:59Z","timestamp":1517020499000},"page":"565-572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4552-1603","authenticated-orcid":false,"given":"Abbas Ali","family":"Tam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didem","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cevdet","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagihan","family":"Bestepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap","family":"Ulusoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuran","family":"Sungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhan","family":"Ersoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bekir","family":"Cakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,27]]},"reference":[{"key":"1523_CR1","doi-asserted-by":"publisher","first-page":"8215834","DOI":"10.1155\/2016\/8215834","volume":"2016","author":"LZ He","year":"2016","unstructured":"L.Z. He, T.S. Zeng, L. Pu, S.X. Pan, W.F. Xia, L.L. Chen, Thyroid hormones, autoantibodies, ultrasonography, and clinical parameters for predicting thyroid cancer. Int. J. Endocrinol. 2016, 8215834 (2016)","journal-title":"Int. J. Endocrinol."},{"key":"1523_CR2","doi-asserted-by":"crossref","first-page":"49930","DOI":"10.18632\/oncotarget.10236","volume":"7","author":"C Li","year":"2016","unstructured":"C. Li, W. Yu, J. Fan et al., Thyroid functional parameters and correlative autoantibodies as prognostic factors for differentiated thyroid cancers. Oncotarget 7, 49930\u201349938 (2016)","journal-title":"Oncotarget"},{"key":"1523_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1089\/thy.2013.0062","volume":"24","author":"DS McLeod","year":"2014","unstructured":"D.S. McLeod, D.S. Cooper, P.W. Ladenson et al.,Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis. Thyroid 24, 35\u201342 (2014)","journal-title":"Thyroid"},{"key":"1523_CR4","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1677\/ERC-09-0150","volume":"16","author":"K Boelaert","year":"2009","unstructured":"K. Boelaert, The association between serum TSH concentration and thyroid cancer. Endocr. Relat. Cancer 16, 1065\u20131072 (2009)","journal-title":"Endocr. Relat. Cancer"},{"key":"1523_CR5","first-page":"4318","volume":"81","author":"P Pujol","year":"1996","unstructured":"P. Pujol, J.P. Daures, N. Nsakala et al., Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 81, 4318\u20134323 (1996)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1523_CR6","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/0002-9343(94)90321-2","volume":"97","author":"EL Mazzaferri","year":"1994","unstructured":"E.L. Mazzaferri, S.M. Jhiang, Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am. J. Med. 97, 418\u2013428 (1994)","journal-title":"Am. J. Med."},{"key":"1523_CR7","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1210\/jc.2011-2735","volume":"97","author":"E Fiore","year":"2012","unstructured":"E. Fiore, P. Vitti, Serum, TSH and risk of papillary thyroid cancer in nodular thyroid disease. J. Clin. Endocrinol. Metab. 97, 1134\u20131145 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1523_CR8","doi-asserted-by":"publisher","first-page":"530721","DOI":"10.1155\/2012\/530721","volume":"2012","author":"C Zafon","year":"2012","unstructured":"C. Zafon, G. Obiols, J.A. Baena et al., Preoperative thyrotropin serum concentrations gradually increase from benign thyroid nodules to papillary thyroid microcarcinomas then to papillary thyroid cancers of larger size. J. Thyroid. Res. 2012, 530721 (2012)","journal-title":"J. Thyroid. Res."},{"key":"1523_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ecl.2014.02.010","volume":"43","author":"DP Momesso","year":"2014","unstructured":"D.P. Momesso, R.M. Tuttle, Update on differentiated thyroid cancer staging. Endocrinol. Metab. Clin. North Am. 43, 401\u2013421 (2014)","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"1523_CR10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1210\/jc.2007-2215","volume":"93","author":"MR Haymart","year":"2008","unstructured":"M.R. Haymart, D.J. Repplinger, G.E. Leverson et al., Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J. Clin. Endocrinol. Metab. 93, 809\u2013814 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1523_CR11","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1210\/jc.2006-0527","volume":"91","author":"K Boelaert","year":"2006","unstructured":"K. Boelaert, J. Horacek, R.L. Holder et al., Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J. Clin. Endocrinol. Metab. 91, 4295\u20134301 (2006)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1523_CR12","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/cen.12027","volume":"78","author":"HK Kim","year":"2013","unstructured":"H.K. Kim, J.H. Yoon, S.J. Kim et al., Higher TSH level is a risk factor for differentiated thyroid cancer. Clin. Endocrinol. 78, 472\u2013477 (2013)","journal-title":"Clin. Endocrinol."},{"key":"1523_CR13","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/hed.21518","volume":"33","author":"KW Kim","year":"2011","unstructured":"K.W. Kim, Y.J. Park, E.H. Kim et al., Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto\u2019s thyroiditis. Head. Neck. 33, 691\u2013695 (2011)","journal-title":"Head. Neck."},{"key":"1523_CR14","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1089\/thy.2011.0146","volume":"21","author":"MR Castro","year":"2011","unstructured":"M.R. Castro, R.P. Espiritu, R.S. Bahn et al., Predictors of malignancy in patients with cytologically suspicious thyroid nodules. Thyroid 21, 1191\u20131198 (2011)","journal-title":"Thyroid"},{"key":"1523_CR15","doi-asserted-by":"publisher","first-page":"dju097","DOI":"10.1093\/jnci\/dju097","volume":"106","author":"S Rinaldi","year":"2014","unstructured":"S. Rinaldi, M. Plummer, C. Biessy et al., Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. J. Natl. Cancer Inst. 106, dju097 (2014)","journal-title":"J. Natl. Cancer Inst."},{"key":"1523_CR16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ando.2011.07.032","volume":"72","author":"A Dorange","year":"2011","unstructured":"A. Dorange, S. Triau, S. Mucci-Hennekinne et al., An elevated level of TSH might be predictive of differentiated thyroid cancer. Ann. Endocrinol. 72, 513\u2013521 (2011)","journal-title":"Ann. Endocrinol."},{"key":"1523_CR17","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1073\/pnas.1015557108","volume":"108","author":"AT Franco","year":"2011","unstructured":"A.T. Franco, R. Malaguarnera, S. Refetoff et al., Thyrotrophin receptor signaling dependence of Braf\u2010induced thyroid tumor initiation in mice. Proc. Natl. Acad. Sci. USA 108, 1615\u20131620 (2011)","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1523_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/thy.2009.0139","volume":"20","author":"M Gerschpacher","year":"2010","unstructured":"M. Gerschpacher, C. G\u00f6bl, C. Anderwald et al., Thyrotropin serum concentrations in patients with papillary thyroid microcancers. Thyroid 20, 389\u2013392 (2010)","journal-title":"Thyroid"},{"key":"1523_CR19","doi-asserted-by":"publisher","first-page":"651","DOI":"10.4158\/EP12385.OR","volume":"19","author":"R Negro","year":"2013","unstructured":"R. Negro, R. Valcavi, F. Riganti et al., Thyrotropin values in patients with micropapillary thyroid cancer versus benign nodular disease. Endocr. Pract. 19, 651\u2013655 (2013)","journal-title":"Endocr. Pract."},{"key":"1523_CR20","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1507\/endocrj.EJ12-0154","volume":"59","author":"L Shi","year":"2012","unstructured":"L. Shi, Y. Li, H. Guan et al., Usefulness of serum thyrotropin for risk prediction of differentiated thyroid cancers does not apply to microcarcinomas: results of 1,870 Chinese patients with thyroid nodules. Endocr. J. 59, 973\u2013980 (2012)","journal-title":"Endocr. J."},{"key":"1523_CR21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/hed.23616","volume":"37","author":"JS Choi","year":"2015","unstructured":"J.S. Choi, C.M. Nam, E.K. Kim et al., Evaluation of serum thyroid-stimulating hormone as indicator for fine-needle aspiration in patients with thyroid nodules. Head. Neck. 37, 498\u2013504 (2015)","journal-title":"Head. Neck."},{"key":"1523_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1177\/0194599815618388","volume":"154","author":"RL Shi","year":"2016","unstructured":"R.L. Shi, T. Liao, N. Qu et al., The usefulness of preoperative thyroid stimulating hormone for predicting differentiated thyroid microcarcinoma. Otolaryngol. Head. Neck. Surg. 154, 256\u2013262 (2016)","journal-title":"Otolaryngol. Head. Neck. Surg."},{"key":"1523_CR23","doi-asserted-by":"crossref","first-page":"34918","DOI":"10.18632\/oncotarget.9201","volume":"7","author":"J Zheng","year":"2016","unstructured":"J. Zheng, C. Li, W. Lu et al., Quantitative assessment of preoperative serum thyrotropin level and thyroid cancer. Oncotarget 7, 34918\u201334929 (2016)","journal-title":"Oncotarget"},{"key":"1523_CR24","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1677\/ERC-09-0036","volume":"16","author":"E Fiore","year":"2009","unstructured":"E. Fiore, T. Rago, M.A. Provenzale et al., Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: Thyroid autonomy may play a protective role. Endocr. Relat. Cancer 16, 1251\u20131260 (2009)","journal-title":"Endocr. Relat. Cancer"},{"key":"1523_CR25","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1210\/jc.2012-1083","volume":"97","author":"DS McLeod","year":"2012","unstructured":"D.S. McLeod, K.F. Watters, A.D. Carpenter et al., Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis. J. Clin. Endocrinol. Metab. 97, 2682\u20132692 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1523_CR26","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/hed.21494","volume":"33","author":"CE Silver","year":"2011","unstructured":"C.E. Silver, R.P. Owen, J.P. Rodrigo et al., Aggressive variants of papillary thyroid carcinoma. Head. Neck. 33, 1052\u20131059 (2011)","journal-title":"Head. Neck."},{"key":"1523_CR27","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1210\/jc.2015-2917","volume":"101","author":"X Shi","year":"2016","unstructured":"X. Shi, R. Liu, F. Basolo et al., Differential clinicopathological risk and prognosis of major papillary thyroid cancer variants. J. Clin. Endocrinol. Metab. 101, 264\u2013274 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1523_CR28","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1089\/thy.2008.0061","volume":"18","author":"J Jonklaas","year":"2008","unstructured":"J. Jonklaas, H. Nsouli-Maktabi, S.J. Soldin, Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer. Thyroid 18, 943\u2013952 (2008)","journal-title":"Thyroid"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-1523-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1523-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1523-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T04:49:37Z","timestamp":1603687777000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-1523-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,27]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["1523"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-1523-6","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,27]]},"assertion":[{"value":"20 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}